Author(s): Andalammal

Email(s): andalrans@ gamil.com

DOI: 10.52711/2454-2660.2021.00090   

Address: Ms. Andalammal
Deputy Nursing Officer, Sri Ramakrishna Hospital.
*Corresponding Author

Published In:   Volume - 9,      Issue - 3,     Year - 2021


ABSTRACT:
Gilbert's syndrome (GS) is a benign condition that does not progress to chronic liver disease or fibrosis. GS diagnosis should be considered in patients with chronic elevation of unconjugated bilirubin. In these patients the presence of hemolysis and other diseases of the liver should be excluded.


Cite this article:
Andalammal. Gilbert Syndrome. International Journal of Nursing Education and Research. 2021; 9(3):385-8. doi: 10.52711/2454-2660.2021.00090

Cite(Electronic):
Andalammal. Gilbert Syndrome. International Journal of Nursing Education and Research. 2021; 9(3):385-8. doi: 10.52711/2454-2660.2021.00090   Available on: https://ijneronline.com/AbstractView.aspx?PID=2021-9-3-32


REFERENCES:
1.    "Gilbert syndrome". GARD. 2016. Archived from the original on 4 August 2017. Retrieved 2 July2017.
2.    "Gilbert Syndrome". NORD (National Organization for Rare Disorders). 2015. Archived from the original on 20 February 2017. Retrieved 2 July 2017.
3.    "Gilbert syndrome". Genetics Home Reference. 27 June 2017. Archived from the original on 27 June 2017. Retrieved 2 July 2017.
4.    "Whonamedit – dictionary of medical eponyms". www.whonamedit.com. Archived from the original on 18 September 2016. Retrieved 2 July 2017.
5.    Kasper et al., Harrison's Principles of Internal Medicine, 16th edition, McGraw-Hill 2005
6.    Boon et al., Davidson's Principles & Practice of Medicine, 20th edition, Churchill Livingstone 2006
7.    Saki, F.; Hemmati, F.; Haghighat, M. (2011). "Prevalence of Gilbert syndrome in parents of neonates with pathologic indirect hyperbilirubinemia". Annals of Saudi Medicine. 31 (2): 140–4. doi:10.4103/0256-4947.77498. PMC 3102472. PMID 21403409.
8.    Bancroft JD, Kreamer B, Gourley GR (1998). "Gilbert syndrome accelerates development of neonatal jaundice". Journal of Pediatrics. 132 (4): 656–60. doi:10.1016/S0022-3476(98)70356-7. PMID 9580766.
9.    Cappellini MD, Di Montemuros FM, Sampietro M, Tavazzi D, Fiorelli G (1999). "The interaction between Gilbert's syndrome and G6PD deficiency influences bilirubin levels". British Journal of Haematology. 104 (4): 928–9. doi:10.1111/j.1365-2141.1999.1331a.x. PMID 10192462. S2CID 40300539.
10.    "Acute bilirubin encephalopathy and its progression to kernicterus: current perspectives".
11.    "Learning from claims: hyperbilirubinaemia and kernicterus".
12.    "Kernicterus".
13.    Marcuello E, Altés A, Menoyo A, Del Rio E, Gómez-Pardo M, Baiget M (2004). "UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer". Br J Cancer. 91 (4): 678–82. doi:10.1038/sj.bjc.6602042. PMC 2364770. PMID 15280927.
14.    Rauchschwalbe S, Zuhlsdorf M, Wensing G, Kuhlmann J (2004). "Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype". Int J ClinPharmacolTher. 42 (2): 73–7. doi:10.5414/cpp42073. PMID 15180166.
15.    Kohle C, Mohrle B, Munzel PA, Schwab M, Wernet D, Badary OA, Bock KW (2003). "Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians". Biochem Pharmacol. 65 (9): 1521–7. doi:10.1016/S0006-2952(03)00074-1. PMID 12732365.
16.    Esteban A, Pérez-Mateo M (1999). "Heterogeneity of paracetamol metabolism in Gilbert's syndrome". European Journal of Drug Metabolism and Pharmacokinetics. 24 (1): 9–13. doi:10.1007/BF03190005. PMID 10412886. S2CID 27543027.
17.    Gilbert Syndrome at eMedicine
18.    Wagner, K. H.; Shiels, R. G.; Lang, C. A.; Seyed Khoei, N.; Bulmer, A. C. (2018). "Diagnostic criteria and contributors to Gilbert's syndrome". Critical Reviews in Clinical Laboratory Sciences. 55 (2): 129–139. doi:10.1080/10408363.2018.1428526. PMID 29390925. S2CID 46870015.
19.    King, D.; Armstrong, M. J. (2019). "Overview of Gilbert's syndrome". Drug and Therapeutics Bulletin. 57 (2): 27–31. doi:10.1136/dtb.2018.000028. PMID 30709860. S2CID 73447592.
20.    Ladislav Novotnýc; Libor Vítek (2003). "Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies". Experimental Biology and Medicine. 228 (5): 568–571. doi:10.1177/15353702-0322805-29. PMID 12709588. S2CID 43486067.
21.    Schwertner Harvey A; Vítek Libor (May 2008). "Gilbert syndrome, UGT1A1 28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin". Atherosclerosis (Review). 198 (1): 1–11. doi:10.1016/j.atherosclerosis.2008.01.001. PMID 18343383.
22.    Vítek L; Jirsa M; Brodanová M; et al. (2002). "Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels". Atherosclerosis. 160 (2): 449–56. doi:10.1016/S0021-9150(01)00601-3. PMID 11849670.
23.    Lin JP; O’Donnell CJ; Schwaiger JP; et al. (2006). "Association between the UGT1A128 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study". Circulation. 114 (14): 1476–81. doi:10.1161/CIRCULATIONAHA.106.633206. PMID 17000907.
24.    Bulmer, A. C.; Verkade, H. J.; Wagner, K.-H. (April 2013). "Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection". Progress in Lipid Research. 52 (2): 193–205. doi:10.1016/j.plipres.2012.11.001. hdl:10072/54228. ISSN 1873-2194. PMID 23201182.
25.    Kundur, Avinash R.; Singh, Indu; Bulmer, Andrew C. (March 2015). "Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome?". Atherosclerosis. 239 (1): 73–84. doi:10.1016/j.atherosclerosis.2014.12.042. ISSN 1879-1484. PMID 25576848.
26.    Gilberts Syndrome.com Archived 2006-08-10 at the Wayback Machine
27.    Olsson R, Bliding A, Jagenburg R, Lapidus L, Larsson B, Svärdsudd K, Wittboldt S (1988). "Gilbert's syndrome—does it exist? A study of the prevalence of symptoms in Gilbert's syndrome". ActaMedicaScandinavica. 224 (5): 485–490. doi:10.1111/j.0954-6820.1988.tb19615.x. PMID 3264448.
28.    Bailey A, Robinson D, Dawson AM (1977). "Does Gilbert's disease exist?". Lancet. 1 (8018): 931–3. doi:10.1016/S0140-6736(77)92226-7. PMID 67389. S2CID 41989158.

29.    Larissa K. F. Temple; Robin S. McLeod; Steven Gallinger; James G. Wright (2001). "Defining Disease in the Genomics Era". Science Magazine. 293 (5531): 807–808. doi:10.1126/science.1062938. PMID 11486074.
30.    del Giudice EM, Perrotta S, Nobili B, Specchia C, d'Urzo G, Iolascon A (October 1999). "Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis". Blood. 94 (7): 2259–62. doi:10.1182/blood.V94.7.2259.419k42_2259_2262. PMID 10498597. Archived from the original on 2013-04-14.
31.    "Entrez Gene: UGT1A1 UDP glucuronosyltransferase 1 family, polypeptide A1". Archived from the original on 2010-12-05.
32.    Raijmakers MT, Jansen PL, Steegers EA, Peters WH (2000). "Association of human liver bilirubin UDP-glucuronyltransferase activity, most commonly due to a polymorphism in the promoter region of the UGT1A1 gene". Journal of Hepatology. 33 (3): 348–351. doi:10.1016/S0168-8278(00)80268-8. PMID 11019988.
33.    Bosma PJ; Chowdhury JR; Bakker C; Gantla S; de Boer A; Oostra BA; Lindhout D; Tytgat GN; Jansen PL; Oude Elferink RP; et al. (1995). "The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome". New England Journal of Medicine. 333 (18): 1171–5. doi:10.1056/NEJM199511023331802. PMID 7565971.
34.    Monaghan G, Ryan M, Seddon R, Hume R, Burchell B (1996). "Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome". Lancet. 347 (9001): 578–81. doi:10.1016/S0140-6736(96)91273-8. PMID 8596320. S2CID 24943762.
35.    J L Gollan; C Bateman; B H Billing (1976). "Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndrome". Gut. 17 (5): 335–340. doi:10.1136/gut.17.5.335. PMC 1411132. PMID 1278716.
36.    N Carulli; M Ponz de Leon; E Mauro; F Manenti; A Ferrari (1976). "Alteration of drug metabolism in Gilbert's syndrome". Gut. 17 (8): 581–587. doi:10.1136/gut.17.8.581. PMC 1411334. PMID 976795.
37.    Gilbert A, Lereboullet P (1901). "La cholémie simple familiale". La Semaine Médicale. 21: 241–3.
38.    Jens EinarMeulengracht at Who Named It?
39.    Foulk, WT; Butt, HR; Owen, CA Jr; Whitcomb, FF Jr; Mason, HL (1959). "Constitutional hepatic dysfunction (Gilbert's disease): its natural history and related syndromes". Medicine (Baltimore). 38 (1): 25–46. doi:10.1097/00005792-195902000-00002. PMID 13632313. S2CID 8265932.
40.    Shmaefsky, Brian (2006). "5". Biotechnology 101. Greenwood Publishing Group. pp. 175. ISBN 978-0-313-33528-0.
41.    "Wire preaches delights of three cliffs". South Wales Evening Post. 2007-04-27. p. 3.
42.    David Cox. (19 April 2014). "A Tennis Player Learns to Be Aggressive for Health's Sake". New York Times. Monte Carlo. Archived from the original on 14 October 2016.
43.    Khorounzhiy, Valentin (2017-11-09). "Illness that 'shut down' Tech3 Moto GP rookie Jonas Folger diagnosed". Autosport.com. Motorsport Network. Retrieved 2017-11-09. After visiting specialists in his native Germany, Folger has been diagnosed with Gilbert's syndrome – a genetic ailment that precludes the liver from correctly processing bilirubin.
44.    Gilbert Syndrome. National Organization for Rare Disorders (NORD). 2015; https://rarediseases.org/rare-diseases/gilbert-syndrome/.
45.    Agner K-H, Shiels RG, Lang CA, Khoei NS, Bulmer AC. Diagnostic criteria and contributors to Gilbert’s syndrome. Critical Reviews in Clinical Laboratory Sciences. 2018; 55(2):129-139. https://www.ncbi.nlm.nih.gov/pubmed/29390925.
46.    Roy-Chowdhury J, Roy-Chowdhury N & Wang X. Gilbert syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction. UpToDate. March 23, 2015; http://www.uptodate.com/contents/gilbert-syndrome-and-unconjugated-hyperbilirubinemia-due-to-bilirubin-overproduction.
47.    Crigler Najjar Syndrome. National Organization for Rare Disorders (NORD). 2016; https://rarediseases.org/rare-diseases/crigler-najjar-syndrome/.
48.    Crigler-Najjar syndrome. Genetics Home Reference (GHR). February, 2012; https://ghr.nlm.nih.gov/condition/crigler-najjar-syndrome.
49.    Gilbert Syndrome. Online Mendelian Inheritance of Man (OMIM). January 12, 2012; http://omim.org/entry/143500.
50.    Gilbert's syndrome. MayoClinic.com. July 2, 2015; http://www.mayoclinic.org/diseases-conditions/gilberts-syndrome/basics/definition/con-20024904?METHOD=print&p=1.

Recomonded Articles:

Author(s): D. Muthukumaran, Danasu, Sridevi

DOI: 10.5958/2454-2660.2020.00089.7         Access: Open Access Read More

Author(s): Andalammal

DOI: 10.52711/2454-2660.2021.00090         Access: Closed Access Read More

International Journal of Nursing Education and Research (IJNER) is an international, peer-reviewed journal devoted to nursing sciences..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5713 

Popular Articles


Recent Articles




Tags